Bellerophon Therapeutics, Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Bellerophon Therapeutics, Inc. reported Increase (Decrease) in Restricted Cash for Operating Activities of -$157.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2017-11-07
- Bellerophon Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-09-30 was -$2.32M.
- Bellerophon Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-06-30 was -$2.32M.
- Bellerophon Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-03-31 was -$2.31M, a 113.04% decline year-over-year.
- Bellerophon Therapeutics, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2014-06-30 was -$2.31M.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month |
|---|---|---|---|
| 2017-09-30 | -$157.00K 10-Q · filed 2017-11-07 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | ||
| 2015-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$4.63M derived: sum of 2 quarters · filed 2016-11-08 | -$6.95M 10-Q · filed 2016-11-08 |
| 2015-06-30 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$4.63M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$2.31M 10-Q · filed 2015-05-15 | ||
| 2014-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $15.44M 10-Q · filed 2015-08-14 | |
| 2014-03-31 | $17.76M 10-Q · filed 2015-05-15 |